During the past decade, Cancer Care Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cancer Care Institute" are "Breakthrough Cancer Pain" (1 trials), "Breast Cancer With Low to Intermediate HER2 Expression" (1 trials), "Cancer of the Lung" (1 trials), "Carcinoma" (1 trials) and "Lung Neoplasms" (1 trials). Many other conditions were trialed in "Cancer Care Institute" in a lesser frequency.

Most popular intervention types in "Cancer Care Institute" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "CO-1.01" (1 trials), "Cetuximab" (1 trials), "Cisplatin" (1 trials), "Fentanyl" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Institute" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Care Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Cancer Care Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".